Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2018-05-07 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于公司证券事务代表减持股份的公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the reduction of shares held by a company's securities affairs representative, including details of the transaction date, number of shares sold, and compliance with relevant stock exchange rules. It does not contain financial statements, management discussion, or report content. It is a notification of a director's or executive's personal share transaction (insider trade). Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on this transaction, confirming it is not a full report or announcement of a report publication.
2018-05-07 Chinese
2018年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a resolution announcement for the 2018 second extraordinary general meeting of shareholders of 三诺生物传感股份有限公司. It details the meeting date, voting methods, attendance, and the voting results on a specific agenda item related to a share transfer agreement. It also includes legal opinions confirming the validity of the meeting and voting process. The document is an official announcement of the voting results from a shareholders' meeting, not the meeting materials or the meeting itself. The length is relatively short (2259 characters), and the content focuses on the voting results and legal validation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-04-26 Chinese
2018年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and results of a specific shareholders' meeting (the 2018 second extraordinary general meeting) of a company. It details the legality and compliance of the meeting's call, attendance, voting procedures, and results. It does not contain financial statements, earnings data, or management discussion of financial results. It is not a report itself but a legal opinion related to a shareholders' meeting. This type of document is best classified as a Regulatory Filing (RNS) because it is a legal compliance document related to corporate governance and shareholder meetings but does not fit into other more specific categories like AGM Information or Declaration of Voting Results, as it is a legal opinion rather than the meeting materials or voting results announcement themselves.
2018-04-26 Chinese
关于2018年度日常关联交易预计公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected related party transactions for the year 2018. It includes descriptions of the nature of the transactions, the parties involved, pricing principles, financial data of the related party, and approvals by the board and independent directors. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about related party transactions, which is a typical regulatory filing. It does not fit into categories like MANG (management changes), CAP (capital updates), or others. Given the content and length (3511 characters), it is best classified as a Regulatory Filing (RNS).
2018-04-24 Chinese
2017年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement from the board of directors of 三诺生物传感股份有限公司 regarding the 2017 annual profit distribution plan. It includes details about the proposed cash dividend and capital reserve conversion to shares, the board's and supervisory board's opinions, and the independent directors' approval. The document explicitly states that the profit distribution plan is subject to approval at the 2017 annual shareholders' meeting. The document length is about 2012 characters, which is relatively short and mainly serves as an announcement of the profit distribution plan rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it is best classified as a Notice of Dividend Amount (DIV) announcement, as it announces the dividend amount, payment basis, and related details for shareholders.
2018-04-24 Chinese
2018年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "三诺生物传感股份有限公司 2018 年第一季度报告全文" which translates to "SanNuo Biological Sensor Co., Ltd. 2018 First Quarter Report Full Text." It contains detailed financial data, including income, profit, cash flow, assets, liabilities, and equity for the first quarter of 2018. It also includes sections on risk factors, shareholder information, business review, and significant events during the quarter. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2018-04-24 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.